Health IT

Here are 9 industry insiders at DIA 2013 to follow on Twitter

Twitter businessThe 49th annual DIA conference, which brings together the different segments of the drug development industry, officially kicks off today in Boston. Clinical trial software developers to pharmaceutical research and development teams and regulators, among others, will look at issues affecting the industry from innovations in clinical trial design, the impact of mobile devices and the use of big data to personalized medicine and regulatory changes. Here are nine industry insiders who are speaking or exhibiting at #DIA2013 to follow on Twitter.

Dr. Daniel Kraft (@daniel_kraft) is a physician and scientist at Stanford University School of Medicine, executive director of FutureMed at Singularity University and is a keynote speaker at the conference.

Cortney Nicolato (@CortneyNic) is the vice president for health care strategies at at @GetReal_Health and is speaking on a panel about innovative partnerships for mobile health at DIA.

Craig Lipset (@CraigLipset) is the head of clinical innovation at Pfizer.


Joe Dustin (@eclinical) is a senior business consultant with Medidata Solutions, cloud-based clinical development solutions provider.

James Valentine (@PublicHlthLwyr) is a program analyst with the FDA’s Office of Health and Constituent Affairs.

Tomasz Sablinski (@TSablinski) is the founder and CEO of Transparency Life Sciences.

Brian Quinn (@quinnhealth) is the team director and senior program officer for the Robert Wood Johnson Foundation

Les Jordan (@ljrdn3) is the chief technology officer for Microsoft Life Science Group which is exhibiting at #DIA2013.

Ritesh Patel (@Ritters90) is the global head of inVentiv Health, a provider of drug development services for to pharmaceutical, biotechnology, generic drug, and medical device companies, which is exhibiting at DIA.

No comments